|
GRSF1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.275400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.631400E-01 |
| Normal-vs-Stage2 |
2.512000E-01 |
| Normal-vs-Stage3 |
7.709000E-01 |
| Normal-vs-Stage4 |
3.623200E-01 |
| Stage1-vs-Stage2 |
1.902600E-01 |
| Stage1-vs-Stage3 |
6.648600E-01 |
| Stage1-vs-Stage4 |
6.193400E-01 |
| Stage2-vs-Stage3 |
2.447400E-01 |
| Stage2-vs-Stage4 |
6.194200E-01 |
| Stage3-vs-Stage4 |
4.023000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.384800E-01 |
| Normal-vs-AfricanAmerican |
2.050800E-01 |
| Normal-vs-Asian |
9.577600E-01 |
| Caucasian-vs-AfricanAmerican |
3.425000E-01 |
| Caucasian-vs-Asian |
9.574200E-01 |
| AfricanAmerican-vs-Asian |
7.041200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.006000E-01 |
| Normal-vs-Female |
2.921200E-01 |
| Male-vs-Female |
4.660400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.337600E-01 |
| Normal-vs-Extreme_Weight |
8.598800E-01 |
| Normal-vs-Obese |
3.764400E-01 |
| Normal-vs-Extreme_Obese |
5.974200E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.496000E-01 |
| Normal_Weight-vs-Obese |
4.333200E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.300200E-01 |
| Extreme_Weight-vs-Obese |
3.546800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.260400E-01 |
| Obese-vs-Extreme_Obese |
8.469400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.584800E-01 |
| Normal-vs-Age(41-60Yrs) |
5.230200E-01 |
| Normal-vs-Age(61-80Yrs) |
4.638000E-01 |
| Normal-vs-Age(81-100Yrs) |
2.171200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.621600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.624200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.533000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.845800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.420000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.377360E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.957810E-01 |
| Normal-VS-Type2 PRCC |
7.598800E-01 |
| Normal-VS-KIRP CIMP |
8.980800E-01 |
| Normal-VS-Unclassified PRCC |
8.693600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.681590E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.683400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.151800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.517200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.189600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.660400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.691200E-01 |
| Normal-vs-N1 |
8.769400E-01 |
| Normal-vs-N2 |
3.058300E-02 |
| N0-vs-N1 |
5.599800E-01 |
| N0-vs-N2 |
2.931800E-01 |
| N1-vs-N2 |
2.687400E-01 |
|
|
